INEOS Nitriles New Acetonitrile Offers 90% Carbon Reduction
INEOS Nitriles has today confirmed the world first sales of INVIREO, a new bio-based Acetonitrile, necessary for the production of many pharmaceuticals such as insulin and vaccines its role in the detection of COVID 19 and its vaccine.
INVIREO Acetonitrile is produced using a controlled and certified (ISCC+) mass balance route which allows INEOS Nitriles to offer customers products with the same performance as conventionally produced acetonitrile, but with a 90% reduction in their carbon footprint.
Gordon Adams, Business Director for INEOS Nitriles and INEOS Phenol businesses said: “This is a significant milestone in the delivery of INEOS Nitriles sustainability strategy.
Our new bio-based acetonitrile has the potential to significantly cut the carbon footprint of pharmaceutical products, which are essential to our everyday lives and healthcare.
“Pharma is an energy-intensive industry, so companies that use our acetonitrile can deliver an immediate cut in their carbon footprint.”
Overall, acetonitrile’s versatility as a high purity solvent and chemical intermediate makes it indispensable in numerous processes, ranging from pharmaceutical manufacturing and analytical chemistry to battery technology and organic synthesis.
Many pharmaceutical molecules are synthesized in solvents, and acetonitrile’s unique properties make it essential for this purpose.
INEOS Nitrate seek to be net zero by 2050
INEOS is the world’s largest producer of Acetonitrile and is the only producer operating in Europe, USA and Asia.
According to their sustainability strategy, penned by Chairman Sir Jim Ratcliffe: “Our INEOS businesses are developing roadmaps to deliver net zero emissions across all of our operations by 2050, whilst remaining profitable and staying ahead of evolving regulations and legislation.
“Based on the roadmaps developed to date, we have set a reduction target of 33% by 2030. We only make pledges that we can support with real world action plans.”
The company’s commitment to sustainability extends into the sectors it serves, and its range of applications includes:
- health and medical devices,
- clean water,
- food conservation and preservation,
- renewable energy products,
- lighter energy saving materials for transport and mobility,
- clothing and apparel
- construction and transmission of water and energy,
- electrical insulation and information technology,
- household and electrical goods.
To achieve their goals, INEOS are committed to investing €6 billion in multiple projects, including supporting the hydrogen economy.
